Letter to the Editor: Saroglitazar for Treatment of NAFLD and NASH

Hepatology. 2021 Dec;74(6):3559-3560. doi: 10.1002/hep.32094. Epub 2021 Sep 16.

Authors

Karan Kumar¹, Anand Kulkarni², Rakesh Kumar Jagdish³

Affiliations

¹ Department of Hepatology, Pacific Institute of Medical Sciences, Udaipur, India.
² Department of Hepatology, Asian Institute of Gastroenterology, Hyderabad, India.
³ Department of Hepatology, Fortis Hospital, Noida, India.

PMID: 34365663
DOI: 10.1002/hep.32094

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Non-alcoholic Fatty Liver Disease* / drug therapy
Phenylpropionates*
Pyrroles

Substances

Phenylpropionates
Pyrroles
saroglitazar